Nautilus Biotechnology Expands Executive Team
Proven leaders in product, finance, and marketing to accelerate the development of Nautilus’ next-generation, single-molecule proteomics analysis platform
SEATTLE & SAN CARLOS, Calif.--(BUSINESS WIRE)-- Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for quantifying the human proteome, today announced the addition of three new members to its executive leadership team: Subra Sankar, SVP of Product Development; Anna Mowry, VP of Finance and Business Operations; and Chris Blessington, VP of Corporate Marketing and Communications. These additions bolster the company’s existing leadership team as Nautilus accelerates the development and ultimate commercialization of its platform.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210105005126/en/
“I’m incredibly excited to welcome Subra, Anna, and Chris to our team as each brings the type of seasoned operational leadership experience Nautilus will need for the next stages of our development,” said Sujal Patel, co-founder and CEO of Nautilus Biotechnology. “This expansion complements our already strong team and provides additional leadership in key functional areas.”
Subra Sankar, SVP of Product Development
Subra joins Nautilus from GenapSys where, as SVP of Product Development, he led the company's R&D efforts including Engineering, Assay, System Integration, Consumable Development, Informatics and a variety of chemistry and molecular biology groups. Subra has held many senior roles over the last 15 years, notably at Solexa/Illumina where, from 2006 to 2012, he led instrument and consumable development efforts for next gen sequencers and related products.
Anna Mowry, VP of Finance & Business Operations
Anna joins Nautilus from Igneous where she served as VP of Finance and Operations with responsibility for finance, accounting, people, legal, and operations. Previously, Anna held a variety of roles at companies including Amazon Web Services, and Isilon Systems, where she ultimately led the finance and sales operations organization. Anna has an undergraduate degree in Biochemistry and started her career at the Fred Hutchinson Cancer Research Institute.
Chris Blessington, VP of Corporate Marketing and Communications
Chris joins Nautilus from Smartsheet where he served as VP of Marketing and Communications with responsibility for creating markets, building awareness, and driving revenue. Prior to that, he led marketing and communications teams at ExtraHop Networks and Isilon Systems through the company's acquisition by EMC. At EMC/Isilon, he also served as executive sponsor of the company’s Life Sciences and Genomics markets, leading product evangelism, market research, and sales preparedness.
ABOUT NAUTILUS BIOTECHNOLOGY
Based in Seattle, Washington with scientific development San Carlos, California, Nautilus is a biotechnology company who is developing a proteomics platform that aims to deliver superior sensitivity far more quickly, more completely, and less expensively than is currently possible. By breaking through the limitations of existing technologies, and effectively democratizing proteomics, Nautilus’ strategic mission is to enable a dramatic acceleration of basic science research, significantly improve the success rate of therapeutic development, and enhance opportunities for personalized and predictive medicine.
Learn more at: www.nautilus.bio
Source: Nautilus Biotechnology